Global Cancer Therapies Market

The Global Cancer Therapies Market is valued at USD XX Billion in 2016 and is poised to reach USD XX Billion by 2022 growing at a CAGR of XX% during the forecast period. Cancer occurs due to the uncontrolled growth of certain type of cells in the body. If untreated, this abnormality can spread to other areas of the body. Cancer is the second largest cause of death across the globe. The novel approaches and personalised medicine development are providing an upgrade to the existing global cancer therapy market.

Market Dynamics

The major growth drivers of the Global Cancer Therapies Market are rising geriatric population, the prevalence of various types of cancer, access to modern treatments and extensive innovation and research in this field.

However, parallel factors like high cost of therapies, uncertain reimbursement policies, difficulties faced in clinical trials and poor rate of healthcare insurance penetration in developing regions are restraining the growth of the market.

Rising number of cancer cases in developing economies and subsequent provision of affordable therapies provide opportunities for expansion for major players.

Market Segmentation

The market is segmented based on therapies into targeted cancer therapies, hormone therapies, immunotherapy and chemotherapy. Targeted cancer therapies include signal transduction inhibitors, gene expression modulators and apoptosis inducers while immunotherapy includes monoclonal antibodies, cancer vaccines and non-specific immunotherapies.

Regional/Geographic Analysis

In terms of geography, the global cancer therapies market is divided into North America, Europe, Asia-Pacific and RoW(Rest of the World). North America and Europe account for 65% of the market share due to extensive oncology spending and easier access to improved healthcare in these regions.

Key Players

Some of the major players in the market include Dendreon, Galena Biopharma, Newlink Genetics, Peregrine Pharmaceuticals and Inovio Pharmaceuticals.

The report contains comprehensive analysis on:

--> Global Cancer Therapies Market Segments

--> Global Cancer Therapies Market Drivers, Restraints and Opportunities

--> Global Cancer Therapies Market Size & Forecast 2016 to 2022

--> Supply & Demand Value Chain

--> Global Cancer Therapies Market Current Trends

--> Competition & Major Companies

--> Technology and R&D Status

--> Porters Five Force Analysis

--> Strategic and Critical Success Factor Analysis of Key Players

Regional analysis for Global Cancer Therapies Market includes

--> North America

>> US and Canada

--> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

--> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

--> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

--> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

--> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Report Highlights::

--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

--> Consumer and Pricing Analysis

--> Market dynamics of the industry

--> In-depth Market Segmentation

--> Historical and Projected Market Sizing in terms of volume and value

--> Recent market trends and Impact Factors

--> R&D Status and Technology Overview

--> Extensive Industry Structure Coverage